The effects of antibiotics on in vitro biofilm model of periodontal disease

European Journal of Medical Research

Volumn 13, Issue 9, 2008, Pages 439-445

  Tamura, A ^a   Ara, T ^a   Imamura, Y ^a   Fujii, T ^b   Wang, Pao Li ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Azithromycin; Biofilm; Erythromycin; Macrolide; Periodontopathic bacteria

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; JOSAMYCIN; MINOCYCLINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; COLORIMETRY; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; SCANNING ELECTRON MICROSCOPY; STREPTOCOCCUS GORDONII;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BIOFILMS; ERYTHROMYCIN; HUMANS; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; STREPTOCOCCUS GORDONII;

EID: 53849093798     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Costerton JW, Stewart PS and Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science (1999) 284: 1318-22
2. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR and Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol (1995) 49: 711-45
3. Donlan RM and Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev (2002) 15: 167-93
4. Wang PL and Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Crit Rev Oral Biol Med (2002) 13: 132-42
5. Helovuo H. and Paunio K. Effects of penicillin and erythromycin on the clinical parameters of the periodontium. J Periodontol (1989) 60: 467-72
6. Slots J. Selection of antimicrobial agents in periodontal therapy. J Periodontal Res (2002) 37: 389-98
7. Walker C and Karpinia K. Rationale for use of antibiotics in periodontics. J Periodontol (2002) 73: 1188-96
8. Walker CB, Karpinia K and Baehni P. Chemotherapeutics: antibiotics and other antimicrobials. Periodontol 2000 (2004) 36: 146-65
9. Wright TL, Ellen RP, Lacroix JM, Sinnadurai S and Mittelman MW. Effects of metronidazole on Porphyromonas gingivalis biofilms. J Periodontal Res (1997) 32: 473-7
10. Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol (2002) 17: 267-71
11. Noiri Y, Okami Y, Narimatsu M, Takahashi Y, Kawahara T and Ebisu S. Effects of chlorhexidine, minocycline, and metronidazole on Porphyromonas gingivalis strain 381 in biofilms. J Periodontol (2003) 74: 1647-51
12. Girard AE, Girard D, English AR, Gootz TD, Cimochowski CR, Faiella JA, Haskell SL and Retsema JA. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother (1987) 31: 1948-54
13. Baldwin DR, Wise R, Andrews JM, Ashby JP and Honeybourne D. Azithromycin concentrations at the sites of pulmonary infection. Eur Respir J (1990) 3: 886-90
14. Davila D, Kolacny-Babic L and Plavsic F. Pharmacokinetics of azithromycin after single oral dosing of experimental animals. Biopharm Drug Dispos (1991) 12: 505-14
15. Blandizzi C, Malizia T, Lupetti A, Pesce D, Gabriele M, Giuca MR, Campa M, Del Tacca M and Senesi S. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. J Periodontol (1999) 70: 960-6
16. Tateda K, Comte R, Pechere JC, Kohler T, Yamaguchi K and Van Delden C. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2001) 45: 1930-3
17. Cook GS, Costerton JW and Lamont RJ. Biofilm formation by Porphyromonas gingivalis and Streptococcus gordonii. J Periodontal Res (1998) 33: 323-7
18. Stinson MW, Safulko K and Levine MJ. Adherence of Porphyromonas (Bacteroides) gingivalis to Streptococcus sanguis in vitro. Infect Immun (1991) 59: 102-8
19. Lamont RJ, Hersey SG and Rosan B. Characterization of the adherence of Porphyromonas gingivalis to oral streptococci. Oral Microbiol Immunol (1992) 7:193-7
20. Nagata H, Amano A, Ojima M, Tanaka M, Kataoka K and Shizukuishi S. Effect of binding of fibrinogen to each bacterium on coaggregation between Porphyromonas gingivalis and Streptococcus oralis. Oral Microbiol Immunol (1994) 9: 359-63
21. Lamont RJ, Bevan CA, Gil S, Persson RE and Rosan B. Involvement of Porphyromonas gingivalis fimbriae in adherence to Streptococcus gordonii. Oral Microbiol Immunol (1993) 8: 272-6
22. Lamont RJ, Hsiao GW and Gil S. Identification of a molecule of Porphyromonas gingivalis that binds to Streptococcus gordonzii. Microb Pathog (1994) 17: 355-60
23. Listgarten MA. The structure of dental plaque. Periodontol 2000 (1994) 5: 52-65
24. Lo Bue AM, Rossetti B, Cali G, Nicoletti G and Condorelli F. Antimicrobial interference of a subinhibitory concentration of azithromycin on fimbrial production of Porphyromonas gingivalis. J Antimicrob Chemother (1997) 40: 653-7
25. Nagino K and Kobayashi H. Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudamonas aeruginosa. Clin Microbiol Infect (1997) 3: 432-9
26. Fuqua WC, Winans SC and Greenberg EP. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol (1994) 176: 269-75
27. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS and Palmer RJ Jr. Communication among oral bacteria. Microbiol Mol Biol Rev (2002) 66: 486-505
28. Sofer D, Gilboa-Garber N, Belz A and Garber NC. 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy (1999) 45: 335-41
29. Greenberg EP. Bacterial communication and group behavior. J Clin Invest (2003) 112: 1288-90
30. Sefton AM, Maskell JP, Beighton D, Whiley A, Shain H, Foyle D, Smith SR, Smales FC and Williams JD. Azithromycin in the treatment of periodontal disease. Effect on microbial flora. J Clin Periodontol (1996) 23: 998-1003
31. Gomi K, Yashima A, Iino F, Kanazashi M, Nagano T, Shibukawa N, Ohshima T, Maeda N and Arai T. Drug concentration in inflamed periodontal tissues after systemically administered azithromycin. J Periodontol (2007) 78: 918-23
32. Fujii T, Wang PL, Hosokawa S, Tamura A, Hikita K, Maida T, Ochi M, Pierre C and Baehni P. Effect of systemically administrated azithromycin in early onset aggressive periodontitis. Perio (2004) 1: 321-5
33. Gladue RP, Bright GM, Isaacson RE and Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother (1989) 33: 277-82
34. Shepard RM, Duthu GS, Ferraina RA and Mullins MA. High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues. J Chromatogr (1991) 565: 321-37
35. Lode H. The pharmacokinetics of azithromycin and their clinical significance. Eur J Clin Microbiol Infect Dis (1991) 10: 807-12
36. Malizia T, Tejada MR, Ghelardi E, Senesi S, Gabriele M, Giuca MR, Blandizzi C, Danesi R, Campa M and Del Tacca M. Periodontal tissue disposition of azithromycin. J Periodontol (1997) 68: 1206-9